Oxaliplatin Fresenius 50 mg/10 ml

Oxaliplatin Fresenius 50 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 61679. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 January 2011 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A
  • Authorisation number 61679
  • Synthetic medicines
Authorisation data
Authorisation number61679
NameOxaliplatin Fresenius 50 mg/10 ml
Full nameOxaliplatin Fresenius 50 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codenot stated
First authorisation11 January 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Oxaliplatin Fresenius 50 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungA11 January 2011
2Oxaliplatin Fresenius 100 mg/20 ml, Konzentrat zur Herstellung einer InfusionslösungA11 January 2011
4Oxaliplatin Fresenius 200 mg/40 ml, Konzentrat zur Herstellung einer InfusionslösungA25 October 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Oxaliplatin Fresenius 50 mg/10 ml authorised in Switzerland?

Yes. Oxaliplatin Fresenius 50 mg/10 ml is authorised by Swissmedic under authorisation number 61679, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Oxaliplatin Fresenius 50 mg/10 ml have?

Oxaliplatin Fresenius 50 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Oxaliplatin Fresenius 50 mg/10 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com